PLEASE FILL IN THE FORM BELOW TO ACCESS

THE FULL REPORT

“Global NeuroTech Industry Landscape Overview 2020” delivers comprehensive market mapping and landscape analysis to identify the key players in NeuroTech, to understand the broad context in which they are operating, and how they are deploying their strategy, products and technologies for investors, customers and other relevant parties, structuring their business, product and technology strategy in order to satisfy unmet market needs and maximize returns. The report enables the identification of critical trends, technologies and approaches shaping the sector, and pinpoints the domains that are well served by existing players, as well as underrepresented areas lacking a critical mass of industry development.

The report offers detailed analysis and insights on a number of industry aspects that are critical for effective strategic decision making, including:

  • Leading NeuroTech companies, investors, NGOs, hubs, conferences, influencers, journalists, research institutions;

  • Market structure, technology usage and implementation;

  • Current and future trends of the NeuroTech industry, and forecasts of the subsectors, markets, regions and technologies with the strongest prospects for growth and diversification within the next several years;

  • Analysis of the most successful and impactful industry players on the market, and the current shape of the global NeuroTech race;

  • Investment opportunities, problems, and risks;

  • Analysis of technology and investment readiness levels for different NeuroTech sectors;

  • Social and ethical implications of NeuroTech;

  • Short- and long-term market predictions;

  • Structural and geographical allocations.

The Global Neurotech Industry is one of the most promising and prospective sectors of modern BioTech in particular and exponential markets in general. Annual growth of investment in neurotechnology is 31% while the average growth for life science investment, in general, is 12%. Private capital funds invested more than $19 billion in NeuroTech companies since the year 2000. Corporations, investors and other counterparties who succeed to tap into the current wave of industry growth and development will gain essential competitive advantages in their struggle for new markets, audiences, funding and technologies. 

 

Some NeuroTech subsectors are already well-established and mature, with practical implementations and products either already on the market or set to appear in the next several years, whereas other subsectors are still emerging, and dominated by early-stage startups. Identifying those sectors with the greatest prospects for short-term growth is one of the most important goals for every player in the industry.